0.00Open15.90Pre Close0 Volume0 Open Interest122.00Strike Price0.00Turnover4282.23%IV2.31%PremiumDec 6, 2024Expiry Date13.39Intrinsic Value100Multiplier-5DDays to Expiry2.51Extrinsic Value100Contract SizeAmericanOptions Type-0.9402Delta0.0176Gamma6.83Leverage Ratio-520.1530Theta0.0000Rho-6.42Eff Leverage0.0002Vega
Novo-Nordisk A/S Stock Discussion
FLOW trial evaluated the risk reduction associated with treatment with Ozempic ® in chronic kidney disease-related events in adults with type 2 diabetes and chronic kidney disease (CKD). FLOW, semag...
The agreement The acquisition of the three production sites was announced on February 5. On May 29, Catalent shareholders voted in favor of the pending transac...
$Novo-Nordisk A/S (NVO.US)$
new
for some reason the profile says its lly
it's so greeen
Add...
No comment yet